410 MEDICAL, INC. — Department of Defense SBIR Phase I: AF211-CSO1
410 MEDICAL, INC. — SBIR Phase I award from Department of Defense.
- Amount
- $50,000
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF211-CSO1
- Solicitation
- X21.1
- NAICS
- —
- Place of performance
- NC
- Period
- 2021-04-14 → 2021-07-19
Description
410 Medical proposes to develop the next generation of the LifeFlow® rapid infusion device optimized for Warfighter resuscitation. The proposed Next Gen LifeFlow will improve patient outcomes and adherence to Tactical Combat Casualty Care guidelines where delivery of blood products is required for hemorrhagic shock in austere environments. Next Gen LifeFlow will become a critical part of the resuscitation toolkit available to military medical personnel.